Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 120 Carcinoma, Hepatocellular 67 Ovarian Neoplasms 63 Neoplasms 36 Carcinoma, Non-Small-Cell Lung 35 Fallopian Tube Neoplasms 29 Glioblastoma 23 Brain Neoplasms 23 Colonic Neoplasms 21 Breast Neoplasms 19 Neoplasm Metastasis 17 Endometrial Neoplasms 17 Uterine Cervical Neoplasms 15 Stomach Neoplasms 15 Rectal Neoplasms 15 Lung Neoplasms 14 Liver Neoplasms 11 Triple Negative Breast Neoplasms 10 Melanoma 8 Glioma 8 Carcinoma, Renal Cell 8 Carcinoma, Ovarian Epithelial 8 Biliary Tract Neoplasms 8 Recurrence 7 Colorectal Cancer Metastatic 7 Squamous Cell Carcinoma of Head and Neck 6 Parkinson Disease 4, Autosomal Dominant Lewy Body 6 Advanced Solid Tumors 6 Small Cell Lung Carcinoma 5 Pancreatic Neoplasms 5

Interventions

trifluridine tipiracil drug combination 2 pegylated granulocyte colony-stimulating factor 2 trilaciclib 1 plerixafor 1 eravacycline 1 Vancomycin 1 Teicoplanin 1 PM 01183 1 Ofloxacin 1 Metronidazole 1 Meropenem 1 Loratadine 1 Levofloxacin 1 Ciprofloxacin 1 Ceftazidime 1 Cefepime 1 Bevacizumab 1 Amikacin 1 Algorithms 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neutropenia × Bevacizumab × 1 year × Clear all

NCT07071844 2025-07-17

BETWEEN

GERCOR - Multidisciplinary Oncology Cooperative Group

Phase 2 Not yet recruiting

Gastrointestinal

Neutropenia, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡